3188 results for «210»
3188 results
Challenging CTO interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
Discover challenging CTO interventions and how to resolve them. Examine a variety of techniques used to manage a lesion that is only crossable by wire, and witness the use of extreme measures to overcome an uncrossable CTO lesion.
Challenging STEMI scenarios: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
Explore a selection of case studies focusing on challenging STEMI scenarios, such as an inferior STEMI with a large thrombus burden, management of coronary dissection in a patient with ectatic coronary artery, and an unusual case of an RCA with an anomalous origin.
Abstracts session 1
06 Dec 2023 – From GulfPCR-GIM 2023
Broaden your knowledge with this selection of abstracts submitted to GulfPCR-GIM 2023, covering topics such as aortic procedures, LV function recovery after CTO recanalization, and the state of PCI in the region of Kurdistan in Iraq.
When complications storm through the cathlab: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
Nightmare in the cathlab
06 Dec 2023 – From GulfPCR-GIM 2023
These presentations focus on complications that may occur during PCI in the cathlab. Through the lens of these cases, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.
Uncommon causes of coronary ischaemia: expect the unexpected!
06 Dec 2023 – From GulfPCR-GIM 2023
Broaden your knowledge and learn about unusual causes of coronary ischaemia. Explore a variety of cases, including the discovery of a coronary fistula, how to diagnose coronary subclavian steal syndrome (CSSS), and more!
Nightmares in TAVI: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.
Imaging for aortic valve disease
18 Feb 2024 – From PCR Tokyo Valves 2024
Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...
Rapid-fire - Pulmonary and tricuspid valve implantation
18 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.
Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis
18 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on transcatheter interventions for tailed mitral valve prosthesis. Learn about unusual solutions, such a reversed loop and parallel wiring to close crescent mitral paravalvular leak, base-to-tip LAMPOON and IABP during a successful mitral valve-in-valve, and more!
Rapid-fire - Bailout in SHD
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).
Complex diagnosis
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Shaping the future of structural heart disease intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
PCR Tokyo Valves 2024 Closing Ceremony
18 Feb 2024 – From PCR Tokyo Valves 2024
The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...
TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
New possibilities in TEER
18 Feb 2024 – From PCR Tokyo Valves 2024
Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...
